Exercise Addiction and Health Risks in Gym Users
Musculoskeletal and Cardiovascular Effects of Exercise Addiction in Recreational Bodybuilders
Saglik Bilimleri Universitesi
32 participants
Jul 29, 2025
OBSERVATIONAL
Conditions
Summary
This observational study aims to investigate the prevalence of musculoskeletal injuries and cardiovascular risk factors among individuals with and without exercise addiction. Adult recreational gym users who have been engaging in resistance training for at least six months will be included. Participants will be divided into two groups based on their exercise dependence levels, and outcomes such as musculoskeletal symptoms, anabolic substance use, and cardiovascular risk scores will be compared between groups.
Eligibility
Inclusion Criteria4
- Aged ≥18 years
- Member of a fitness center
- Regular physical activity (≥3 times per week)
- Voluntary participation with informed consent
Exclusion Criteria3
- Diagnosed psychiatric illness
- Professional or elite athletes
- Incomplete questionnaire data
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants in this observational study will not receive any therapeutic intervention. Instead, all individuals will undergo a series of standardized non-invasive assessments for data collection purposes. These include the Exercise Dependence Scale-21 (EDS-21) to classify exercise addiction status, the Drive for Muscularity Scale (DMS) to evaluate body image and muscle-related attitudes, and the Extended Nordic Musculoskeletal Questionnaire to determine the presence and severity of musculoskeletal symptoms. Cardiovascular risk will be assessed using the SCORE Risk Assessment System, which incorporates blood pressure, cholesterol, blood glucose, smoking status, and demographic data. Additional measurements will include oxygen saturation and heart rate using pulse oximetry, and blood pressure using a sphygmomanometer. These evaluations are intended solely for comparative analysis between exercise-dependent and non-dependent groups.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07061509